loader
Please Wait
Applying Filters...

Evonik Evonik

X

List of Certificates of Suitability (CEPs) for r0_cep_2000_385___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Aventis Pharma Deutschland GmbH Bad Soden DE (1)

filter

01 Aprotinin concentrated solution (1)

filter

01 France (1)

filter

01 Expired (1)

URL Supplier Web Content
R0-CEP 2000-385 - Rev 01
Expired
TSE
2005-02-18
2007-01-24
579
Sanofi Company Banner

Vietnam Medi Pharm 2024

Not Confirmed

envelop Contact Supplier

Looking for Certificates of Suitability (CEPs) for R0-CEP 2000-385 - Rev 01 of Aventis Pharma Deutschland Gmbh Bad Soden De

Looking for Certificates of Suitability (CEPs) for R0-CEP 2000-385 - Rev 01 of Aventis Pharma Deutschland Gmbh Bad Soden De 1

20

Aventis Pharma Deutschland Gmbh Bad Soden De, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

One of their significant offerings is Aprotinin concentrated solution, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2000-385 - Rev 01

This TSE Type CEP, issued on February 18, 2005, remains in force until January 24, 2007, ensuring its reliability within the pharmaceutical industry.

Substance Number 579 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY